Company

IAMA Therapeutics

Pharmaceutical Manufacturing Genova, IT 8 employees GNTA

Employees: 8
Contacts: 2
Emails: 2

iamatherapeutics.com LinkedIn Crunchbase

IAMA Therapeutics Overview

Headquarters: Genova, IT
Website: iamatherapeutics.com
Industry: Pharmaceutical Manufacturing
Employees: 8
Founded: 2021
Stock Symbol: GNTA
Funding: 17.1M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Foresee Biosystems

About IAMA Therapeutics

IAMA Therapeutics is a clinical-stage pharmaceutical company raising a Series B to fund the clinical development of its lead candidate in epilepsy and neurodevelopment disorders. The Company’s lead candidate, IAMA-6, is a "best-in-class" selective NKCC1 inhibitor being developed for various orphan brain disorders, including drug-resistant epilepsy, and started the Phase 1 clinical trial in January 2024. Other pipeline candidates include new molecular entities to target Cation Chloride Cotransporters in pediatric neuropsychiatric conditions.

IAMA Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

IAMA Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Paul Frohna, Md, Phd	Passionate About Biotechnology	San Diego, California, United States	View
Marco Dieci	CEO - Biotech & Pharma - Atmps & Life	Italy	Email
Marco Borgogno	Head Chemistry & Cmc @ Iama Therapeutics	Greater Genoa Metropolitan Area, Italy	View
Paul Frohna	Chief Medical Officer & Science	United States	Email